ADVANCEMENTS IN ASTHMA MEDICATION: A COMPREHENSIVE ANALYSIS
Keywords:
1. Asthma 2. Medicatio 3. Advancements 4. Inhalers 5. Corticosteroids 6. Bronchodilators 7. Biologics 8. Personalized medicine 9. Clinical trials 10. Patient outcomesAbstract
Advancements in asthma medication have significantly improved the management and treatment of this chronic respiratory condition. Over the years, researchers and pharmaceutical companies have developed innovative drugs and treatment strategies to help individuals with asthma better control their symptoms and improve their quality of life.
References
Global Initiative for Asthma (GINA). (2021). Global Strategy for Asthma Management and Prevention. Retrieved from https://ginasthma.org/gina-reports/
American Thoracic Society. (2020). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. American Journal of Respiratory and Critical Care Medicine, 171(8), 912-930. doi:10.1164/rccm.200406-710ST
Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J., Pauwels, R. A., . . . Wolfe, J. (2008). Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. American Journal of Respiratory and Critical Care Medicine, 170(8), 836-844. doi:10.1164/rccm.200802-334OC
Busse, W. W., Lemanske Jr, R. F., & Gern, J. E. (2010). Role of viral respiratory infections in asthma and asthma exacerbations. The Lancet, 376(9743), 826-834. doi:10.1016/S0140-6736(10)61380-3
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., . . . Adcock, I. M. (2014). International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. European Respiratory Journal, 43(2), 343-373. doi:10.1183/09031936.00202013
Sutherland, E. R. (2014). Nocturnal asthma: underlying mechanisms and treatment. Current Allergy and Asthma Reports, 14(5), 440. doi:10.1007/s11882-014-0440-0
Wenzel, S. E. (2012). Asthma: defining of the persistent adult phenotypes. The Lancet, 380(9842), 811-823. doi:10.1016/S0140-6736(12)61089-2
